Avid Bioservices, Inc. (CDMOP)

$ 25.06
+0.01 (+0.04%)
-
Symbol CDMOP
Price $ 25.06
Beta 2.696
Volume Avg. 0.01M
Market Cap 0.21B
Shares () -
52 Week Range 23.348-31.95
1y Target Est -
DCF Unlevered CDMOP DCF ->
DCF Levered CDMOP LDCF ->
ROE 19.89% Buy
ROA 4.73% Neutral
Operating Margin -
Debt / Equity 506.08% Strong Buy
P/E -
P/B 31.73 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest CDMOP news


Mr. Richard B. Hancock
Healthcare
Biotechnology
Nasdaq Capital Market

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, purification, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. It serves biotechnology and pharmaceutical companies. Avid Bioservices, Inc. has a process development and manufacturing agreement with Oragenics, Inc. to develop coronavirus vaccine. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was founded in 1981 and is headquartered in Tustin, California.